Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
US-10072003-B2 · Sep 11, 2018 · US
Merck Canada Inc was listed as an assignee on 2 patent publications in 2018.
| Metric | Value |
|---|---|
| Company | Merck Canada Inc |
| Year | 2018 |
| Patents | 2 |
Representative publications for Merck Canada Inc in 2018.
US-10072003-B2 · Sep 11, 2018 · US
US-9994587-B2 · Jun 12, 2018 · US
Most common classification codes for Merck Canada Inc in 2018.
| CPC | Patents |
|---|---|
| C07D471/04 | 2 |
| A61K31/4375 | 1 |
| A61K31/5375 | 1 |
| A61K31/5377 | 1 |
| A61K31/5386 | 1 |
Navigate to parent entity pages.